vs
Side-by-side financial comparison of Community Healthcare Trust Inc (CHCT) and Electromed, Inc. (ELMD). Click either name above to swap in a different company.
Community Healthcare Trust Inc is the larger business by last-quarter revenue ($31.5M vs $18.9M, roughly 1.7× Electromed, Inc.). Electromed, Inc. runs the higher net margin — 14.6% vs 8.1%, a 6.5% gap on every dollar of revenue. On growth, Electromed, Inc. posted the faster year-over-year revenue change (16.3% vs 4.8%). Over the past eight quarters, Electromed, Inc.'s revenue compounded faster (16.7% CAGR vs 7.0%).
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.
CHCT vs ELMD — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $31.5M | $18.9M |
| Net Profit | $2.5M | $2.8M |
| Gross Margin | — | 78.4% |
| Operating Margin | — | 19.2% |
| Net Margin | 8.1% | 14.6% |
| Revenue YoY | 4.8% | 16.3% |
| Net Profit YoY | 60.2% | 40.3% |
| EPS (diluted) | — | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $31.5M | — | ||
| Q4 25 | $30.9M | $18.9M | ||
| Q3 25 | $31.1M | $16.9M | ||
| Q2 25 | $29.1M | $17.4M | ||
| Q1 25 | $30.1M | $15.7M | ||
| Q4 24 | $29.3M | $16.3M | ||
| Q3 24 | $29.6M | $14.7M | ||
| Q2 24 | $27.5M | $14.8M |
| Q1 26 | $2.5M | — | ||
| Q4 25 | $14.4M | $2.8M | ||
| Q3 25 | $1.6M | $2.1M | ||
| Q2 25 | $-12.6M | $2.2M | ||
| Q1 25 | $1.6M | $1.9M | ||
| Q4 24 | $1.8M | $2.0M | ||
| Q3 24 | $1.7M | $1.5M | ||
| Q2 24 | $-10.4M | $1.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 78.4% | ||
| Q3 25 | — | 78.1% | ||
| Q2 25 | — | 78.3% | ||
| Q1 25 | — | 78.0% | ||
| Q4 24 | — | 77.7% | ||
| Q3 24 | — | 78.3% | ||
| Q2 24 | — | 76.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 19.2% | ||
| Q3 25 | — | 15.8% | ||
| Q2 25 | — | 17.5% | ||
| Q1 25 | — | 13.6% | ||
| Q4 24 | — | 15.6% | ||
| Q3 24 | — | 13.2% | ||
| Q2 24 | — | 15.7% |
| Q1 26 | 8.1% | — | ||
| Q4 25 | 46.6% | 14.6% | ||
| Q3 25 | 5.3% | 12.6% | ||
| Q2 25 | -43.2% | 12.7% | ||
| Q1 25 | 5.3% | 12.1% | ||
| Q4 24 | 6.3% | 12.1% | ||
| Q3 24 | 5.9% | 10.0% | ||
| Q2 24 | -37.9% | 12.3% |
| Q1 26 | — | — | ||
| Q4 25 | $0.52 | $0.32 | ||
| Q3 25 | $0.03 | $0.25 | ||
| Q2 25 | $-0.50 | $0.26 | ||
| Q1 25 | $0.03 | $0.21 | ||
| Q4 24 | $0.04 | $0.22 | ||
| Q3 24 | $0.04 | $0.16 | ||
| Q2 24 | $-0.42 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.6M | $13.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $421.3M | $45.4M |
| Total Assets | $1.0B | $54.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $2.6M | — | ||
| Q4 25 | $3.3M | $13.8M | ||
| Q3 25 | $3.4M | $14.1M | ||
| Q2 25 | $4.9M | $15.3M | ||
| Q1 25 | $2.3M | $15.2M | ||
| Q4 24 | $4.4M | $16.2M | ||
| Q3 24 | $2.8M | $13.9M | ||
| Q2 24 | $734.0K | $16.1M |
| Q1 26 | — | — | ||
| Q4 25 | $532.2M | — | ||
| Q3 25 | $530.1M | — | ||
| Q2 25 | $500.1M | — | ||
| Q1 25 | $496.0M | — | ||
| Q4 24 | $486.0M | — | ||
| Q3 24 | $473.7M | — | ||
| Q2 24 | $457.6M | — |
| Q1 26 | $421.3M | — | ||
| Q4 25 | $429.4M | $45.4M | ||
| Q3 25 | $426.8M | $44.7M | ||
| Q2 25 | $437.8M | $43.2M | ||
| Q1 25 | $461.3M | $43.9M | ||
| Q4 24 | $476.0M | $43.6M | ||
| Q3 24 | $477.2M | $41.5M | ||
| Q2 24 | $497.8M | $44.5M |
| Q1 26 | $1.0B | — | ||
| Q4 25 | $990.8M | $54.9M | ||
| Q3 25 | $987.3M | $53.6M | ||
| Q2 25 | $966.3M | $53.8M | ||
| Q1 25 | $985.1M | $52.5M | ||
| Q4 24 | $992.6M | $52.3M | ||
| Q3 24 | $981.8M | $48.9M | ||
| Q2 24 | $983.2M | $52.2M |
| Q1 26 | — | — | ||
| Q4 25 | 1.24× | — | ||
| Q3 25 | 1.24× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.02× | — | ||
| Q3 24 | 0.99× | — | ||
| Q2 24 | 0.92× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $3.0M |
| Free Cash FlowOCF − Capex | — | $2.4M |
| FCF MarginFCF / Revenue | — | 12.7% |
| Capex IntensityCapex / Revenue | — | 3.4% |
| Cash ConversionOCF / Net Profit | — | 1.10× |
| TTM Free Cash FlowTrailing 4 quarters | — | $7.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $56.4M | $3.0M | ||
| Q3 25 | $12.7M | $169.0K | ||
| Q2 25 | $13.8M | $3.9M | ||
| Q1 25 | $14.4M | $2.1M | ||
| Q4 24 | $58.9M | $3.2M | ||
| Q3 24 | $13.8M | $2.3M | ||
| Q2 24 | $16.7M | $4.5M |
| Q1 26 | — | — | ||
| Q4 25 | $35.9M | $2.4M | ||
| Q3 25 | $7.6M | $-83.0K | ||
| Q2 25 | $9.6M | $3.7M | ||
| Q1 25 | $9.7M | $1.9M | ||
| Q4 24 | $34.2M | $2.9M | ||
| Q3 24 | $6.7M | $2.3M | ||
| Q2 24 | $9.5M | $4.5M |
| Q1 26 | — | — | ||
| Q4 25 | 116.0% | 12.7% | ||
| Q3 25 | 24.6% | -0.5% | ||
| Q2 25 | 32.9% | 21.4% | ||
| Q1 25 | 32.3% | 12.2% | ||
| Q4 24 | 116.9% | 18.0% | ||
| Q3 24 | 22.5% | 15.5% | ||
| Q2 24 | 34.7% | 30.1% |
| Q1 26 | — | — | ||
| Q4 25 | 66.3% | 3.4% | ||
| Q3 25 | 16.3% | 1.5% | ||
| Q2 25 | 14.5% | 0.8% | ||
| Q1 25 | 15.6% | 1.0% | ||
| Q4 24 | 84.1% | 1.4% | ||
| Q3 24 | 24.2% | 0.3% | ||
| Q2 24 | 26.1% | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | 3.91× | 1.10× | ||
| Q3 25 | 7.76× | 0.08× | ||
| Q2 25 | — | 1.75× | ||
| Q1 25 | 9.06× | 1.10× | ||
| Q4 24 | 32.14× | 1.60× | ||
| Q3 24 | 7.92× | 1.57× | ||
| Q2 24 | — | 2.46× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CHCT
Segment breakdown not available.
ELMD
| Homecare | $17.3M | 91% |
| Other | $1.6M | 9% |
